Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Q1 FY2018
As of Mar 31, 2018
Q4 FY2017
As of Dec 31, 2017
Assets
Current assets
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Real estate assets, held-for-sale, net
Real estate securities, available-for-sale
Other current assets
Total current assets
Restricted cash, noncurrent
Property and equipment, net of accumulated depreciation
Operating lease right-of-use assets
Intangibles, net of accumulated amortization
Other investments
Other assets
Total assets
Liabilities and Equity
Current liabilities
Obligations under finance leases
Accounts payable and accrued expenses
Deferred revenue
Membership deposit liabilities
Total deferred revenue
Real estate liabilities, held-for-sale
Other current liabilities
Total current liabilities
Credit facilities and obligations under finance leases - noncurrent
Operating lease liabilities - noncurrent
Junior subordinated notes payable
Membership deposit liabilities, noncurrent
Deferred revenue, noncurrent
Other liabilities
Total liabilities
Equity
Preferred stock, $0.01 par value, 100,000,000 shares authorized, 1,347,321 shares of 9.75% Series B Cumulative Redeemable Preferred Stock, 496,000 shares of 8.05% Series C Cumulative Redeemable Preferred Stock, and 620,000 shares of 8.375% Series D Cumulative Redeemable Preferred Stock, liquidation preference $25.00 per share, issued and outstanding as of September 30, 2022 and December 31, 2021
Common stock, $0.01 par value, 1,000,000,000 shares authorized, 92,385,019 and 92,093,425 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively.
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Total equity of the company
Noncontrolling interest
Total equity (deficit)
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support